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Abstract
Background: Gestational diabetes mellitus (GDM) is a global public health concern with potential implications for
the health of a mother and her offspring. However, data on the prevalence and risk factors of GDM in Latin
America are scarce.
The study was designed to estimate the prevalence of GDM and identify maternal risk factors among Peruvian
women.
Methods: A cross-sectional study was conducted among 1300 pregnant women attending a prenatal clinic in
Lima, Peru. GDM was diagnosed using an Oral Glucose Tolerance Test (OGTT) performed between 24 and 28
gestational weeks using the International Association of Diabetes and Pregnancy Study Groups (IADPSG) criteria.
Depression status was assessed using the Patient Health Questionnaire-9. Multivariate logistic regression models
were used to identify risk factors of GDM.
Results: Approximately 16% of pregnant women were diagnosed with GDM. The prevalence of obesity and
depression were 24.4 and 10.6%, respectively. After adjusting for confounders, mid-pregnancy obesity was
associated with a 1.64-fold increased odds of GDM (OR: 1.64; 95% CI: 1.03–2.61). Participants with a family history of
diabetes had a 1.5-fold increased odds of developing GDM (OR: 1.51, 95% CI: 1.10–2.07) as compared to women
without this family history. Depression was associated with a 1.54-fold increased odds of GDM (OR: 1.54; 95%
CI:1.09–2.17).
Conclusions: GDM is highly prevalent and was associated with maternal obesity, family history of diabetes and
antepartum depression among Peruvian women. Intervention programs aimed at early diagnoses and management
of GDM need to take maternal obesity, family history of diabetes and antepartum depression into account.
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Background
Gestational diabetes mellitus (GDM) is a
non-communicable disease affecting pregnant women
[1, 2]. Globally the median estimates of GDM range
from 6 to 13% [2]. In the United States, recent estimates
show up to 9% of all pregnancies are complicated by
GDM [3]. In Central and South America, the recent
overall prevalence of GDM is estimated at 11% [2].
There is well-established evidence showing that women
with GDM are at risk for preeclampsia [4, 5], premature
birth [6], increased risk of cesarean section [4, 5] and
later development of type 2 diabetes [2]. GDM is also as-
sociated with increased risk of perinatal complications
including malformations [7], shoulder dystocia [5], neo-
natal hypoglycemia [8], and perinatal mortality [8, 9].
Obesity and a family history of diabetes have been
consistently identified as major risk factors for GDM in
previous studies [3]. Other risk factors for GDM include
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advanced maternal age [10], nonwhite race [10, 11], pre-
vious unexplained stillbirth [12, 13], and obesity [10, 13].
In addition to increased GDM risk, maternal obesity
increases the risk of multiple adverse maternal health
outcomes including thrombosis [14], gestational hyper-
tension [15], preeclampsia [16–18], preterm delivery
[19], and cesarean section [16, 18]. Of note, significant
neonatal complications have been associated with obes-
ity and GDM. These include congenital anomalies [20,
21], macrosomia [22], and birth injury [23, 24]. An
expanding body of evidence now implicates unipolar
major depressive disorder as one of the major risk fac-
tors for and conditions co-occurring with GDM [25], al-
though the evidence is inconsistent [26].
Peru, a middle-income country, is one of the countries
experiencing an epidemiologic transition with increasing
burden of non-communicable disease risk factors [27, 28].
A 2014 national survey in Peru of people ≥15 years old
showed the prevalence of overweight is 35% and the
prevalence of obesity is 18% of the population [29]. How-
ever, the prevalence of GDM and its risk factors have not
been investigated in Peru. Given this gap in the literature
and the increased burden of non-communicable diseases
in the country, we sought to examine the prevalence of
GDM and associated risk factors in a cohort of pregnant
women in Lima, Peru.
Methods
Study population
The Screening Treatment and Effective Management of
Gestational Diabetes Mellitus (STEM-GDM) was de-
signed to evaluate the prevalence of GDM among Peru-
vian women attending perinatal care and to provide
evidence to improve the local guidelines for standardized
GDM screening/diagnosis, effective management, and
treatment. Participants were 1300 pregnant women at-
tending prenatal care clinic at the Instituto Nacional
Materno Perinatal (INMP) in Lima, Peru (Additional file 1).
Recruitment occurred between February 2013 and June
2014. The Instituto Nacional Materno Perinatal
(INMP), overseen by the Peruvian Ministry of Health,
is the primary referral center for maternal and perinatal
care in Lima, Peru.
Women were eligible if they were at least 18 years of age,
had a gestational age of 24 to 28 gestational weeks, and
could speak, read and write Spanish. Participants were ex-
cluded if they planned to deliver at another hospital or loca-
tion, date of last menstrual period not certain and not
confirmed by ultrasound exam performed prior to 24 weeks
of gestation, unable to complete an oral glucose tolerance
test (OGTT), known to have a multiple pregnancy, had a
previous diagnosis of overt diabetes requiring treatment
with medication before the pregnancy, or were currently re-
ceiving medical treatment for chronic diseases, such as oral
glucocorticoids, thiazide diuretics, β-blockers, ACE inhibi-
tors, oral β-mimetics, Dilantin, or antiretroviral agents. All
participants provided written informed consent. Study pro-
cedures were approved by institutional review boards of the
INMP, Lima, Peru and the Harvard T.H. Chan School of
Public Health Office of Human Research Administration,
Boston, MA, USA.
Gestational Diabetes Mellitus (GDM) assessment
GDM cases were identified using the OGTT, which is
considered the gold standard for this diagnosis. For the
OGTT test, participants were appointed to the labora-
tory at INMP between 8 AM to 9 AM after 8-h over-
night fasting. A trained lab technician obtained a basal
venous blood sample of 15cm3 for measuring fasting
plasma glucose (PG). Participants were administered
75 g of anhydrous oral glucose dissolved in 250 ml of
water. After 1 and 2 h, new venous blood samples were
obtained for measuring PG levels. Plasma glucose value
was measured by the glucose oxidase-peroxidase method
in duplicate using an auto-analyzer for biochemical tests.
Standard clinical laboratory quality control assessment
of the OGTT testing was completed to assure reliability
and validity of measured plasma glucose.
Interpretation of the OGTT
According to the standard OGTT testing procedures
outlined by the IADPSG recommendations [30], preg-
nant women were considered to have GDM if fasting
plasma glucose (PG) was ≥92 mg/dl (5.1 mmol/l), 1 h-h
PG ≥180 mg/dl (10 mmol/l), and/or 2-h PG ≥153 mg/dL
(≥8.5 mmol/L). Overall, 205 women were diagnosed with
GDM. Of the GDM diagnosed women, 186 women
(90.7%) had a fasting PG ≥ 92 mg/dl, 29 women (14.1%)
had a 1-h PG ≥180 mg/dl, and 24 women (11.7%) had a
2-h PG ≥153 mg/dL. Women diagnosed with GDM re-
ceived glucometers, nutritional advice, and clinical care
to manage their condition.
Sociodemographic characteristics
Women were interviewed using a structured question-
naire to collect detailed information on sociodemographic,
lifestyle characteristics, medical and reproductive history.
Sociodemographic information collected included partici-
pants’ age, family history of diabetes mellitus among first
degree-relatives, body weight, height, smoking status, and
alcohol use. Other covariates included maternal and pater-
nal education (≤6, 7–12, > 12 years); ethnicity (Mestizo vs.
others); marital status (married/living with partner vs.
others); employment status (employed vs. not employed);
difficulty paying for the basics (very hard/hard, somewhat
hard, not very hard); difficulty accessing medical care (very
hard/hard, somewhat hard, not very hard); food insecurity
(no vs. yes), and perceived health during pregnancy.
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Pre-pregnancy body mass index (BMI) and mid-pregnancy
BMI were calculated as weight (in kilograms) divided by
the square of height (in meters and used to identify normal
weight (BMI < 25 kg/m2), overweight (BMI: 25–29.9 kg/
m2), and obese (BMI ≥ 30 kg/m2)) women. Due to the small
number of underweight women, this group was merged
with normal weight women. For the purpose of our ana-
lysis, obesity was grouped into a single category of BMI of
30.0 kg/m2 and higher. Depression status was assessed
using the 9-item Spanish-language Patient Health
Questionnaire-9 (PHQ-9) [31, 32], which has been vali-
dated in a population of pregnant Peruvian women [33].
The PHQ-9 score was calculated by assigning a score be-
tween 0 and 3 to the response categories of “not at all,”
“several days,” “more than half the days,” and “nearly every
day.” Depression was defined as a PHQ-9 score ≥ 10.
Statistical analysis
Sociodemographic characteristics were evaluated using
numbers (%) for categorical variables and means
(± standard deviations) for continuous variables.
Chi-square tests and Student’s t-tests were conducted to
compare distributions between women with and without
GDM. Prevalence estimates were determined for GDM
in relation to socio-demographic and behavioral charac-
teristics. Adjusting for covariates of interest, we used
multivariable logistic regression procedures to calculate
odds ratios (OR) and 95% confidence intervals (95% CI)
to estimate associations of GDM with risk factors. For-
ward logistic regression modeling procedures combined
with the change-in-estimate approach were used to se-
lect the final report models [34]. Variables of a priori
interest (e.g., age and BMI) were forced into final
models. All analyses were performed using IBM’s SPSS
Statistical Software for Windows (IBM SPSS Version 22,
Chicago, Illinois, USA). All reported p-values are
two-sided and deemed statistically significant at α = 0.05.
Results
Maternal sociodemographic and reproductive character-
istics of the study population are presented in Table 1.
The average age of study participants was 28.9 years
(± 6.1). A majority of participants were married or living
with a partner (86.5%), Mestizo (98.1%), and un-
employed (67.8%) (Table 1). The overall prevalence of
GDM in our population of Peruvian pregnant women
was 15.8%. The prevalence of mid-pregnancy obesity
was 24.5% while 10.6% of them had depression. Com-
pared to women without GDM, women with GDM were
significantly older (p = 0.013), more likely to report a
family history of diabetes (p = 0.005), have higher
mid-pregnancy BMI (p = 0.016) and have depression
(p = 0.012). The prevalence of GDM increased signifi-
cantly with the presence of family history of diabetes
mellitus (p = 0.005) and maternal mid-pregnancy obesity
(p = 0.02) (Fig. 1).
In an unadjusted bivariate analysis, participants with a
family history of diabetes had 1.53-fold increased risk of
GDM (OR: 1.53, 95%CI: 1.13–2.07), and participants with
mid-pregnancy obesity had 1.83-fold increased risk of
GDM compared to those of normal weight (OR: 1.83,
95%CI: 1.19–2.81) (Table 2). Compared to non-depressed
participants, those with depression had a 1.5-fold in-
creased odds of GDM (OR: 1.52, 95%CI: 1.09–2.12). After
adjusting for age and family history of diabetes, the associ-
ation between depression status and GDM remained sig-
nificant (OR: 1.53, 95%CI: 1.09–2.14). In a multivariate
model, a family history of diabetes remained significantly
associated with GDM (OR: 1.51, 95%CI: 1.10–2.07),
mid-pregnancy obesity slightly increased the risk for
GDM (OR: 1.64, 95%CI: 1.03–2.61), and depression was
also significantly associated with GDM (OR: 1.54, 95%CI:
1.09–2.17) (Table 2).
Discussion
To the best of our knowledge, this is the first study to
examine the prevalence of GDM in Lima, Peru using the
IADPSG criteria, as well as the presence of family his-
tory of diabetes mellitus, maternal mid-pregnancy obes-
ity, and maternal depression as independent risk factors
of GDM. Approximately 16% of pregnant women were
diagnosed with GDM. The prevalence of obesity was
24% and the prevalence of depression was 11%. A previ-
ous study by Sacks et al. using IADPSG criteria and a
multinational cohort (n = 23,957) reported the preva-
lence of GDM varies from 9 to 26% and is associated
with older maternal age, BMI, family history of diabetes,
mean OGTT glucose values, and ethnicity [35]. Globally,
the prevalence of GDM varies by study setting and diag-
nostic criteria. Additional influencing factors include
age, obesity, and use of health services. For instance,
using International Classification of Diseases (ICD) diag-
nostic codes (ICD-9 and ICD-10), GDM prevalence was
reported as 6% in the USA [36], and 10% in Korea [37].
A meta-analysis of 22 studies in sub-Saharan Africa with
a range of diagnostic criteria and study setting reported
a GDM prevalence of 2–6% [13]. A study in China using
a 75-g 2-h OGTT reported a GDM prevalence of 8%. A
higher percentage of GDM diagnoses were made by fast-
ing PG than 1- or 2-h glucose levels compared to previ-
ous estimates.
We found a significant association between GDM and
mid-pregnancy obesity (BMI > 25). Maternal age of
30 years or older and family history of diabetes were also
significantly associated with GDM. Our results are in
general agreement with previous studies that have iden-
tified similar associations with GDM risk factors. For ex-
ample, Kumari et al., found a GDM prevalence of 24.5%
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Table 1 Maternal sociodemographic characteristics (N = 1300)
Characteristics All participants (N = 1300) No GDM (N = 1095) GDM (N = 205) P-value
n % n % n %
Maternal age (years)a 28.86 ± 6.14 28.68 ± 6.06 29.83 ± 6.49 0.013
Maternal age (years)
< 19 49 3.8 43 3.9 6 2.9 0.081
20–29 669 51.5 578 52.8 91 44.4
30–34 313 24.1 258 23.6 55 26.8
≥35 269 20.7 216 19.7 53 25.9
Ethnicity
Mestizo 1275 98.1 1074 98.1 201 98.0 0.974
Other 25 1.9 21 1.9 4 2.0
Marital status
Married or living with partner 1123 86.5 946 86.5 177 86.3 0.960
Single or living alone/divorced 176 13.5 148 13.5 28 13.7
Educational Status (years) 12.17 ± 2.38 12.16 ± 2.39 12.25 ± 2.33 0.604
Maternal education (years)
≤6 39 3.0 34 3.1 5 2.4 0.743
7–12 698 53.7 591 54.0 107 52.2
> 12 563 43.3 470 42.9 93 45.4
Paternal education (years)
≤6 30 2.3 27 2.5 3 1.5 0.318
7–12 727 56.4 620 57.0 107 53.0
> 12 532 41.3 440 40.5 92 45.5
Employment
No 881 67.8 733 66.9 148 72.2 0.140
Yes 419 32.2 362 33.1 57 27.8
Pre-pregnancy BMI (kg/m2)
< 25 (normal weight) 684 53.6 580 53.8 104 52.3 0.137
25–29.9 (overweight) 446 34.9 382 35.4 64 32.2
≥30 (obese) 147 11.5 116 10.8 31 15.6
Mid-pregnancy BMI (kg/m2)
< 25 (normal weight) 324 25.0 284 26.1 40 19.5 0.016
25–29.9 (overweight) 653 50.5 553 50.8 100 48.8
≥30 (obese) 317 24.5 252 23.1 65 31.7
Family history of diabetes
No/Don’t Know 834 64.2 720 65.8 114 114 0.005
Yes 466 35.8 375 34.2 91 44.4
Depression 138 10.6 106 9.7 32 15.6 0.012
Perceived health during pregnancy
Excellent 18 1.4 14 1.3 4 2.0 0.696
Very Good 76 5.8 67 6.1 9 4.4
Good 586 45.1 488 44.6 98 47.8
Fair 568 43.7 483 44.1 85 41.5
Poor 52 4.0 43 3.9 9 4.4
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in obese compared to 2.2% in non-obese women
(P < 0.0001) [38]. In a retrospective cohort study of 613
obese (BMI > 35; class II and III) and 11,313 non-obese
women, there was a threefold increase of GDM for
obese patients compared to non-obese women (OR: 3.2,
95%CI: 2.5–4.2) [39]. In a recent meta-analysis of pub-
lished literature, Chu and colleagues reported ORs of de-
veloping GDM of 2.14 (95% CI: 1.82–2.53), 3.56 (95%
CI: 3.05–4.21), and 8.56 (95% CI: 5.07–16.04) among
overweight, obese, and severely obese compared with
normal-weight pregnant women, respectively [40]. Ac-
cording to Kim et al. in a study of pregnant women
from Florida, USA, the likelihood of GDM increased
with increasing BMI was significant for all racial/eth-
nic groups investigated [41]. Additionally, the propor-
tion of GDM cases attributable to overweight and
obesity was 41.1% overall [41]. The HAPO Study Co-
operative Research Group has demonstrated that
Table 1 Maternal sociodemographic characteristics (N = 1300) (Continued)
Characteristics All participants (N = 1300) No GDM (N = 1095) GDM (N = 205) P-value
n % n % n %
Difficulty paying for basics
Very hard/hard 199 15.3 171 15.6 28 13.7 0.759
Somewhat hard 441 34.0 369 33.8 72 35.1
Not very hard 658 50.7 553 50.6 105 51.2
Food insecurity
No 446 34.3 379 34.6 67 32.7 0.593
Yes 854 65.7 716 65.4 138 67.3
Difficulties to access medical care
Very hard/hard 248 19.1 207 18.9 41 20.0 0.728
Somewhat hard 897 69.1 760 69.5 137 66.8
Not very hard 154 11.9 127 11.6 27 13.2
amean ± standard deviation
Italicized p-values are statistically significant at α = 0.05
Fig. 1 Prevalence of GDM by family history of diabetes mellitus among first degree-relatives, maternal age, pre-pregnancy BMI, and mid-pregnancy
BMI. Point estimates and 95%CI are reported
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Table 2 Prevalence and risk factors of gestational diabetes (N = 1300)
Characteristics Crude OR (95%CI) Age and family history of
diabetes adjusted OR (95%CI)a
Multivariate OR (95%CI)b
Maternal age (years) 1.03 (1.01–1.06) – 1.03 (1.00–1.06)
Ethnicity
Mestizo Reference Reference Reference
Other 1.02 (0.35–3.00) 1.05 (0.35–3.10) 1.01 (0.34–3.02)
Marital status
Married or living with partner Reference Reference Reference
Single or living alone/divorced 1.01 (0.66–1.56) 1.10 (0.70–1.71) 1.04 (0.66–1.66)
Maternal education (years)
≤6 Reference Reference Reference
7–12 1.23 (0.47–3.22) 0.79 (0.3–2.11) 1.13 (0.42–3.03)
> 12 1.35 (0.51–3.53) 0.92 (0.69–1.27) 1.13 (0.41–3.10)
Partner education (years)
≤6 Reference Reference Reference
7–12 1.55 (0.46–5.21) 0.52 (0.15–1.76) 1.72 (0.50–5.88)
> 12 1.88 (0.56–6.34) 0.85 (0.63–1.16) 1.98 (0.57–6.86)
Pre-pregnancy BMI (kg/m2)
< 25 (normal weight) Reference Reference Reference
25–29.9 (overweight) 0.93 (0.67–1.31) 0.86 (0.61–1.21) 0.90 (0.63–1.27)
≥30 (obese) 1.49 (0.95–2.33) 1.22 (0.76–1.95) 1.29 (0.80–2.07)
Mid-pregnancy BMI (kg/m2)
< 25 (normal weight) Reference Reference Reference
25–29.9 (overweight) 1.28 (0.87–1.90) 1.18 (0.79–1.77) 1.23 (0.82–1.87)
≥30 (obese) 1.83 (1.19–2.81) 1.54 (0.98–2.41) 1.64 (1.03–2.61)
P-value for trend 0.033
Family history of diabetes
No/Don’t know Reference – Reference
Yes 1.53 (1.13–2.07) – 1.51 (1.10–2.07)
Depression
No Reference Reference Reference
Yes 1.52 (1.09–2.12) 1.53 (1.09–2.14) 1.54 (1.09–2.17)
Perceived health during pregnancy
Excellent Reference Reference Reference
Very good 0.47 (.13–1.74) 0.52 (0.14–1.93) 0.62 (0.16–2.34)
Good 0.70 (0.23–2.18) 0.75 (0.24–2.35) 0.89 (0.28–2.82)
Fair 0.62 (0.20–1.92) 0.63 (0.20–1.97) 0.69 (0.22–2.21)
Poor 0.73 (0.20–2.75) 0.73 (0.19–2.76) 0.76 (0.20–2.92)
Difficulty paying for basics
Very hard/hard Reference Reference Reference
Somewhat hard 1.19 (0.74–1.91) 1.24 (0.77–1.99) 1.18 (0.73–1.93)
Not very hard 1.16 (0.74–1.82) 1.25 (0.79–1.97) 1.19 (0.74–1.91)
aAdjusted for age (continuous) and family history of diabetes mellitus among first degree-relatives (yes vs. no/don’t know)
bMain multivariate regression model adjusted for all characteristics (maternal age, ethnicity, marital status, maternal education, paternal education, mid-pregnancy
BMI, family history of diabetes, depression, perceived health during pregnancy, and difficulty paying for the basics) except pre-pregnancy BMI and OR (95%CI)
from this model are reported here. A second multivariate regression model adjusted for all covariates except mid-pregnancy BMI and the OR (95%CI) for pre-
pregnancy BMI is reported from this model
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higher maternal BMI is associated with increased
likelihood of pregnancy complications, including com-
plications related to fetal growth, adiposity, and pre-
eclampsia [42].
There is a growing body of epidemiologic evidence that
shows depression as a risk factor for GDM [43, 44]. Our
study results showing a significant association between de-
pression and GDM is in general agreement with some prior
studies [25, 43] but not all [26]. Recently, a longitudinal
study in the USA from Hinkle et al. found that persistently
high depression scores in the 1st and 2nd trimesters were
associated with three-fold increased risk of GDM (highest
vs lowest quartile in both trimesters: RR: 3.21, 95%
CI: 1.00–10.28) [43]. In a cross-sectional study, women
with GDM were more than three times more likely to have
a history of depression compared to non-depressed women
(OR: 3.79, 95% CI: 1.07–13.45) [25]. However, using data
from prenatal care clinics at a University of Washington
Medical Center, Katon et al. found no evidence of
association between GDM and antepartum depression
(OR = 0.95; 95%CI: 0.68–1.33) [26]. In a addition, a 2016
meta-analysis shows there is no clear consensus on the as-
sociation between depression and diabetes during preg-
nancy and additional studies are needed [45]. Although we
do not have a clear explanation for these findings, we
speculate that differences in nutrition, physical activity, and
other lifestyle characteristics may have contributed to the
observed differences. Pregnancy is a major life event that
increases vulnerability to depression, and pregnant women
who have comorbid depression and GDM with serious im-
plications for both maternal and infant outcomes.
This study had several strengths, including the use of
trained interviewers and standard laboratory procedures
for measuring plasma glucose. Our relatively large sam-
ple size and the high prevalence of gestational diabetes
give us statistical power to study the associations of
interest. However, some limitations must be considered
when interpreting the results of our study. First, a family
history of diabetes was assessed based on self-report;
therefore, we cannot rule out recall bias. Additionally,
previous studies have shown associations between GDM
and adverse pregnancy outcomes. However, information
on pregnancy outcomes was not collected in our study
cohort. Lastly, participants in this study were pregnant
women living in Lima, and the results may not be
generalizable to the whole Peruvian population. Future
studies that collect objective measures potentially associ-
ated with GDM and obesity may overcome concerns
about these potential errors.
Conclusion
Overweight and obesity may be prevented by implement-
ing a healthy lifestyle that includes physical activity and
nutritional counseling before pregnancy. If women are
already obese when they become pregnant, O’Dwyer et al.
suggests early screening for women with a body mass
index > 34.9 kg/m in order to optimize maternal glycemic
control during pregnancy [46]. In a retrospective cohort
study, Lutsic et al. found that the proportion of women
with maternal or delivery complications was highest
among overweight or obese depressed pregnant women
[47]. These studies provide evidence of a high prevalence
of GDM in women with an elevated mid-pregnancy BMI
and depression. GDM is prevalent in this population, es-
pecially in overweight/obese and depressed pregnant
women. Our findings may be used to develop and imple-
ment programs aimed at supporting high-risk mothers in
antenatal care.
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